Ian Karp | VP, IR and Public Relations |
Dr. Michael Kauffman | CEO |
Mike Mason | CFO |
Anand Varadan | Chief Commercial Officer |
Brian Abrahams | RBC Capital Markets |
David Ruch | SVB Leerink |
Good morning. My name is Gigi and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics First Quarter 2019 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the Company’s request.